Archives

by in
Entry Author Date Location
Texas Biotech ZS Pharma Makes Wall Street Debut, Raises $107M 06/18/14 Texas
A Few Raindrops Amid Texas Biotech IPO Drought 05/30/14 Texas
ZS Pharma Ends Texas Biotech IPO Dry Spell With $86M Pitch 05/20/14 Texas
ZS Pharma Raises $55M to Develop Drug to Treat Hyperkalemia 03/06/14 Texas
ZS Pharma Passes Key Test With Drug for Hyperkalemia 11/20/13 Texas
Sanitas Gets FDA Clearance to Market ‘Wellaho’ for Chronically Ill 02/20/13 San Diego
Keryx Finally Succeeds With a Clinical Trial, for Kidney Disease Drug 01/28/13 New York
Undaunted by Wall Street “Penalty Box,” Keryx Focuses on Kidney Drug 05/22/12 New York
Progress for Pervasis and InVivo: A Boost for Regenerative Efforts? 04/19/12 Boston
Another $15.2M for Proteon 08/12/11 Boston
Amag Pharma Cutting 68 Jobs 11/01/10 Boston
AlloCure Arrives in New England, Merck Shutters Cambridge Research Site, Infinity Cuts Deal With Intellikine, & More Boston-Area Life Sciences News 07/09/10 Boston
AlloCure, With Stem Cell Therapy for Kidney Failure, Arrives in New England with New CEO 07/06/10 Boston
Medify, Incubated at Voyager Capital, Raises $1.3M to Reshape Health IT for Consumers 07/01/10 Seattle
Genzyme in “Tough Spot” with Icahn Proxy Challenge—CEO Termeer Courting Key Shareholders 05/13/10 Boston
Amag Pharma to Sell 3M Shares 01/20/10 Boston
Genzyme Resumes Shipments of Gaucher’s Drug from Allston Plant 12/01/09 Boston
Genzyme Halts Development of New Kidney Drug; A “Very Significant” Bust, Analyst Says 11/18/09 Boston
Amira Pharmaceuticals’ Experimental Lung Disease Drug May Have Legs 07/01/09 San Diego
Proteon Fills Coffers with $38M Round, Inks Deal for Potential Sale to Novartis 03/05/09 Boston
AMAG Pharma Awaiting FDA Word on New Iron-Replacement Drug 02/04/09 Boston
Genzyme Shares Climb as Competing Kidney Drug Stumbles 01/27/09 Boston
Page 1 of 1